Results 161 to 170 of about 374,595 (258)

Role of liposomal amphotericin B in intensive care unit: an expert opinion paper. [PDF]

open access: yesJ Anesth Analg Crit Care
Bussini L   +16 more
europepmc   +1 more source

Nimodipine reduces microglial activation in vitro as evidenced by morphological phenotype, phagocytic activity and high‐throughput RNA sequencing

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Nimodipine, an L‐type voltage‐gated calcium channel blocker, is an approved cerebral vasorelaxant. We hypothesized that nimodipine attenuates the pro‐inflammatory shift in microglial phenotypes. Here, we analysed the effects of nimodipine on morphological and functional microglial phenotypes as well as their transcriptomic ...
István Pesti   +10 more
wiley   +1 more source

Correction: Evaluation and testing of polymethylmetacrylic (PMMA) bone cements with admixed Amphotericin B. [PDF]

open access: yesJ Orthop Surg Res
Frank FA   +6 more
europepmc   +1 more source

Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole [PDF]

open access: green, 1981
Robert H.K. Eng   +4 more
openalex   +1 more source

Antitumor Activities by a Humanized Cancer‐Specific Anti‐Podoplanin Monoclonal Antibody humPMab‐117 Against Human Tumors

open access: yesCancer Science, EarlyView.
A humanized cancer‐specific anti‐podoplanin monoclonal antibody humPMab‐117 exerts antibody‐dependent cellular cytotoxicity and complement‐dependent cytotoxicity against human tumor cells. In the xenograft tumor models, humPMab‐117 demonstrated strong antitumor efficacy.
Tomohiro Tanaka   +5 more
wiley   +1 more source

Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA). [PDF]

open access: yesAntimicrob Agents Chemother
Thompson GR   +11 more
europepmc   +1 more source

DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance

open access: yesCell Proliferation, EarlyView.
Glioblastoma (GBM) stem cells are useful model for in vitro drug characterisation. DNA repair mechanisms can contribute to cancer cell survival. Pt(IV) bearing Histone DeACetylase inhibitors enhances anticancer effects by disrupting DNA damage response. Poly ADP ribose polymerases inhibitors could adjuvate GBM treatment.
Ludovica Gaiaschi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy